Consistent Guidelines and reviews recommend using clinical history and examination to guide the evaluation.Moderate Targeted tests are more useful when they answer defined clinical questions.Limited A symptom cluster alone suggests several hypotheses but does not confirm a hormonal or nutritional deficiency.Does not demonstrate An educational vignette cannot establish causation, protocol efficacy, or an expected outcome.

Starting with the full picture

In this vignette, an adult woman with regular menstrual cycles seeks an evaluation for persistent symptoms affecting her energy, routine, and quality of life. Her most prominent concern is severe fatigue in the morning that improves later in the day. She also describes low motivation, difficulty concentrating, recent-memory concerns, and greater effort required to remain physically active.

Other symptoms involve several areas: hair loss, brittle nails, sensitivity to cold, cold hands and feet, dry skin, acne, and oily skin. She also experiences emotional and physical worsening before her period, including irritability, mood swings, bloating, breast tenderness, and occasional migraine attacks.

Sexual health concerns include reduced desire, vaginal dryness, and difficulty reaching orgasm. Stress-related digestive symptoms, low water intake, and a history of constipation are also included in the constructed scenario.

Why a symptom list does not establish a diagnosis

Many of these symptoms are nonspecific. Fatigue and difficulty concentrating, for example, may be associated with insufficient sleep, emotional distress, anemia, thyroid disorders, medications, inadequate nutrition, infections, inflammatory disease, or other conditions. More than one contributor may be present at the same time.

The same reasoning applies to hair loss and low sexual desire. Hair loss should be characterized by its pattern and duration, examination of the scalp, and clinical context. Sexual function involves physical, emotional, relational, hormonal, medication-related, and sociocultural factors. No isolated testosterone value can, by itself, explain a woman's sexual desire.

Similar symptoms can have different causes. One person may also have a clinical condition, insufficient sleep, stress, and reproductive or nutritional factors at the same time.

How the evaluation can be organized

Rather than beginning with a predetermined diagnosis, a responsible evaluation can be structured around clinical questions:

  • when each symptom began, how it changed, and whether it is worse at a particular time of day or phase of the menstrual cycle;
  • sleep duration and quality, work routine, physical activity, nutrition, hydration, and bowel habits;
  • menstrual, reproductive, emotional, and sexual history, including the symptoms' effect on daily life;
  • medications and supplements already used, perceived benefits, adverse effects, and possible interactions;
  • physical examination and signs that may focus the evaluation or require more urgent care;
  • additional tests selected according to the clinical hypotheses, without treating a broad laboratory panel as a substitute for an evaluation.

Possibilities to consider include hematologic abnormalities or iron deficiency, thyroid function, nutritional deficiencies, mental health, sleep, gynecologic factors, and other conditions compatible with the history. A clinical hypothesis is not a diagnosis; it must be examined against findings, test results, and the clinical course.

The vignette intentionally provides no laboratory results and assigns no hormonal deficiency, thyroid disorder, menopausal transition, or other diagnosis. Its purpose is to demonstrate the process that comes before a diagnostic conclusion.

How to interpret an uneven course

For teaching purposes, the vignette includes an evolution in which energy and morning fatigue improve substantially and physical activity becomes easier to resume. Premenstrual symptoms, migraine attacks, palpitations, and some digestive and cold-related concerns also lessen.

Hair loss and memory and concentration concerns improve only partly. Low sexual desire and difficulty reaching orgasm remain important. The course is therefore not uniform, and those concerns require their own reassessment.

The scenario also includes nausea and stomach discomfort that occur in temporal association with a product and improve after it is stopped. Without a controlled rechallenge or another method of confirmation, this may suggest intolerance but cannot identify the responsible ingredient with certainty.

Follow-up is not only a record of improvement. It is also a way to identify persistent symptoms, adverse effects, and new information that requires the plan to be reconsidered.

How evidence helps interpret the vignette

Fatigue

Clinical reviews recommend beginning with the history and physical examination, including symptom pattern, sleep, mood, substances, medications, and signs of systemic illness. Indiscriminate testing can produce incidental findings without explaining the concern.

Thyroid function

Fatigue, constipation, dry skin, cold sensitivity, and mood changes may occur with hypothyroidism, but they are not specific to it. TSH and free T4 help characterize thyroid function. In subclinical hypothyroidism, decisions depend on the persistence and degree of the abnormality, age, symptoms, antibodies, pregnancy or reproductive plans, and cardiovascular risk.

Premenstrual symptoms

Timing in relation to the menstrual cycle is central. When a premenstrual disorder is suspected, prospective daily symptom tracking for at least two cycles helps distinguish a premenstrual pattern from symptoms that continue throughout the month. Care is multimodal and depends on severity and functional impact.

Vitamin D, iron, and hair loss

A laboratory abnormality can coexist with symptoms without being their only cause. Recent guidelines advise against routine vitamin D screening in generally healthy adults without an established indication. In nonscarring hair loss, studies report an association with lower iron stores in some women, but causation, a universal ferritin threshold, and the benefit of supplementation without confirmed deficiency remain debated.

Low sexual desire and testosterone

International consensus statements recommend a comprehensive biopsychosocial evaluation before hormonal treatment is considered. Reduced desire is considered a disorder only when it is persistent and causes clinically meaningful personal distress. The best-supported indication for testosterone is hypoactive sexual desire disorder in carefully selected postmenopausal women. Evidence is insufficient for generalized use before menopause or for treating nonspecific symptoms.

What this vignette helps illustrate

  • symptoms involving different systems should be organized over time and within the person's broader context;
  • partial or uneven change can help redefine clinical priorities;
  • tolerability and safety need to be reassessed at each follow-up;
  • tests are most useful when they answer a concrete clinical question.

What this vignette does not demonstrate

  • it does not confirm one cause for all symptoms;
  • it does not establish a hormonal or nutritional abnormality without the relevant results and diagnostic criteria;
  • it does not prove that a medication, supplement, or combination caused the improvement described in the scenario;
  • it cannot predict another person's course or support reproducing a plan outside an individual evaluation.

A vignette is a teaching tool, not evidence of an effect. Even real case reports may generate hypotheses but cannot replace comparative studies: they do not control for natural history, placebo effects, simultaneous lifestyle changes, regression to the mean, or other influences on an outcome.

Frequently asked questions

Do these symptoms mean hypothyroidism?

Not necessarily. They may occur with hypothyroidism, but they also occur in many other conditions. Diagnosis depends on the clinical context and appropriate testing.

Does low sexual desire mean testosterone deficiency?

No. Sexual desire is multifactorial, and one laboratory value does not establish the cause of the concern or automatically define an indication for treatment.

If several symptoms improve, is the treatment proven?

No. Even when this course occurs in a real case, one observation cannot separate each intervention's effect from other factors and does not establish efficacy for other people.

Why are doses and formulas not published?

Clinical decisions depend on diagnosis, test results, risks, concurrent medications, reproductive plans, and monitoring. Publishing a prescription outside that context could encourage unsafe replication and would not add scientific validity to the vignette.

From a short post to the full context

The post introduces the clinical question. This written version documents the reasoning, limitations, and references.

Follow @dreliastamer

Key references

  1. Kornder N, Baum E, Maisel P, Lindner N. Tiredness/Fatigue—S3 guideline update. Zeitschrift für Allgemeinmedizin. 2023;99:127-132.
  2. Latimer KM, Gunther A, Kopec M. Fatigue in Adults: Evaluation and Management. American Family Physician. 2023;108(1):58-69.
  3. National Institute for Health and Care Excellence. Thyroid disease: assessment and management. NICE Guideline NG145.
  4. American College of Obstetricians and Gynecologists. Management of Premenstrual Disorders: ACOG Clinical Practice Guideline No. 7. Obstetrics & Gynecology. 2023;142(6):1516-1533.
  5. Davis SR et al. Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Journal of Clinical Endocrinology & Metabolism. 2019;104(10):4660-4666.
  6. Parish SJ et al. ISSWSH Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. Journal of Women's Health. 2021;30(4):474-491.
  7. Demay MB et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. 2024;109(8):1907-1947.
  8. Treister-Goltzman Y, Yarza S, Peleg R. Iron Deficiency and Nonscarring Alopecia in Women: Systematic Review and Meta-Analysis. Skin Appendage Disorders. 2022;8(2):83-92.
  9. Gagnier JJ et al. The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development. Journal of Clinical Epidemiology. 2014;67(1):46-51.
Continue in the Evidence Center

Compare what guidelines support about hormones after age 35 and about the diagnosis and treatment of hypothyroidism.

Explore the evidence